Dr. Joseph D. Ciacci, MD
Neurosurgery (Neurological Surgery Physician)
200 W Arbor Dr
San Diego, CA 92103
Who else practices at this address →
San Diego County includes primary care (1% of residents) and mental health (1% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 37
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 54
Licensed in California since 2004, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurological Surgery Physician primary
CA license A50933 (first issued 2004; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- UC San Diego Health Hillcrest - Hillcrest Med Ctr San Diego, CA
Medical groups
- Regents of the University of California (2,089 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 54
- Services billed
- 98
- Patients’ average age
- 71
| Service | Times | Patients |
|---|---|---|
| New patient office or other outpatient visit, 45-59 minutes | 19 | 19 |
| Established patient office or other outpatient visit, 30-39 minutes | 17 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 3 companies reported 13 payments worth $32,043 in total to this clinician.
| Neo Spine USA, Inc. | $31,736 |
|---|---|
| Orthofix Medical, Inc. | $214 |
| Xtant Medical Inc | $91.87 |
| Consulting Fee | $29,250 |
|---|---|
| Food and Beverage | $1,457 |
| Travel and Lodging | $1,336 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Neo Spine USA, Inc. Mar 18, 2025 | Consulting Fee Neo Pedicle Screw System · Spinal Surgery | $29,250 |
| Neo Spine USA, Inc. Nov 19, 2025 | Travel and Lodging Neo Pedicle Screw System · Spinal Surgery · travel to Dallas, TX | $1,000 |
| Neo Spine USA, Inc. Nov 19, 2025 | Travel and Lodging Neo Pedicle Screw System · Spinal Surgery · travel to Dallas, TX | $336 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $1,396,503 in research payments for these studies, mostly to the institutions running them.
- Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II)
Sumitomo Pharma Co., Ltd. · Recruiting · NCT06482268 - A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease
Sumitomo Pharma America, Inc. · Recruiting · NCT06753331
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.